Endotracheal Intubation Using Alfentanil in a Pediatric Patient with a Mitochondrial Myopathy and Gastroparesis

Abstract

Children with mitochondrial disorders represent a subset of patients who require unique anesthetic considerations. Routinely administered medications for general anesthesia, such as propofol, have been shown to increase the risk of developing metabolic acidosis. In addition, both depolarizing and nondepolarizing neuromuscular blockers are contraindicated due to the risk of hyperkalemic cardiac arrest and worsening of preexisting muscle weakness, respectively. These limitations pose challenges while choosing appropriate medications for induction of general anesthesia, especially when the risk of aspiration is high. We present a novel case of using inhaled sevoflurane and intravenous alfentanil to facilitate intubation in a 4-year-old girl with a complex 1 mitochondrial disorder suffering from severe gastroparesis and esophageal dysmotility.

Keywords

alfentanil - general anesthesia - mitochondrial disease

Publikationsverlauf

Eingereicht: 14. November 2019

Angenommen: 15. Januar 2020

Artikel online veröffentlicht:
17. Februar 2020

• References

• 1 Yeoh C, Teng H, Jackson J. et al. Metabolic disorders and anesthesia. Curr Anesthesiol Rep 2019; 9 (03) 340-359
• 2 Rafique MB, Cameron SD, Khan Q, Biliciler S, Zubair S. Anesthesia for children with mitochondrial disorders: a national survey and review. J Anesth 2013; 27 (02) 186-191
• 3 Smith A, Dunne E, Mannion M. et al. A review of anaesthetic outcomes in patients with genetically confirmed mitochondrial disorders. Eur J Pediatr 2017; 176 (01) 83-88
• 4 Footitt EJ, Sinha MD, Raiman JAJ, Dhawan A, Moganasundram S, Champion MP. Mitochondrial disorders and general anaesthesia: a case series and review. Br J Anaesth 2008; 100 (04) 436-441
• 5 Scaglia F, Towbin JA, Craigen WJ. et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 2004; 114 (04) 925-931
• 6 Sumi C, Okamoto A, Tanaka H. et al. Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner. PLoS One 2018; 13 (02) e0192796
• 7 Driessen J, Willems S, Dercksen S, Giele J, van der Staak F, Smeitink J. Anesthesia-related morbidity and mortality after surgery for muscle biopsy in children with mitochondrial defects. Paediatr Anaesth 2007; 17 (01) 16-21
• 8 Schieren M, Defosse J, Böhmer A, Wappler F, Gerbershagen MU. Anaesthetic management of patients with myopathies. Eur J Anaesthesiol 2017; 34 (10) 641-649
• 9 Finsterer J, Stratil U, Bittner R, Sporn P. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth 1998; 45 (08) 781-784
• 10 Gurunathan U, Kunju SM, Stanton LML. Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports. BMC Anesthesiol 2019; 19 (01) 213
• 11 Scheller MS, Zornow MH, Saidman LJ. Tracheal intubation without the use of muscle relaxants: a technique using propofol and varying doses of alfentanil. Anesth Analg 1992; 75 (05) 788-793
• 12 Robinson DN, O'Brien K, Kumar R, Morton NS. Tracheal intubation without neuromuscular blockade in children: a comparison of propofol combined either with alfentanil or remifentanil. Paediatr Anaesth 1998; 8 (06) 467-471
• 13 Choong K, AlFaleh K, Doucette J. et al. Remifentanil for endotracheal intubation in neonates: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2010; 95 (02) F80-F84